Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed May 20, 2013 · 10-Q · 50 days after period end · 0001144204-13-030545
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | — | $14.93K | $120.27K |
| Net Income | -$473.30K | -$1.09M | -$638.23K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 20, 2013 · 50 d after period end
